Developer of pharmaceuticals. The company offers medicines used in the treatment of HIV, cardiovascular disease, central nervous system disorders, cancer and inflammatory diseases.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore DuPont (Dymel Pharma Business)‘s full profile, request access.
Request a free trial